lung cancerIt is one of the deadliest diseases in the world. So much so that it kills about 1.8 million people every year. For this reason, scientists are constantly conducting research on lung cancer.

Now, a revolutionary development has taken place in the field of lung cancer. The biotech giant founded by Uğur Şahin and Özlem Türeci BioNTech, started testing the world’s first lung vaccine.

Tests will be carried out in 7 countries, including Turkey

based in the United Kingdom Janusz Racz, 67 years old A named lung cancer patient made history as the first person to receive the vaccine. It was reported that the vaccine will be tested in six other countries in addition to the UK. Under this There is also Turkey. Others are AGermany, Spain, Poland, Hungary and the United States.

The vaccine developed by BioNTech BNT116 has the name. It’s about mRNA technology, like the COVID vaccine. What he does is prevents the immune system from recognizing and attacking cancer cells to ensure. In this way cancer cells destroy and foodWhy prevent them from happening? is intended. Vaccine, non-small cell lung cancer (NSCLC) designed to target. NSCLC accounts for 85% of lung cancer cases.

The study will involve experiments at 34 research centers in 7 countries. Tests will include surgery and radiotherapy to treat patients at different stages of the disease, from patients with advanced stages of the disease. 130 patients participated will show.

We will see over time what results the vaccine, which is described as revolutionary, will bring. We hope that it is successful and can save the lives of millions of people around the world.